Time-course changes of nLDL-induced erectile dysfunction
- PMID: 28298622
- DOI: 10.1038/ijir.2017.5
Time-course changes of nLDL-induced erectile dysfunction
Abstract
Hyperlipidemia is an important risk factor for atherosclerosis and is frequently seen in patients with erectile dysfunction (ED). This study was designed to evaluate whether the acute effect of native low-density lipoprotein (nLDL) on intracavernosal pressure (ICP) is reversible and related to plasma asymmetrical dimethylarginine (ADMA), endogenous inhibition of endothelial nitric oxide synthase (eNOS) levels and eNOS expression in cavernous tissues. Hyperlipidemia was induced by a single dose of intravenous 4 mg kg-1 nLDL. Experiments were performed 72 h (72H), 2 weeks (2W) and 8 weeks (8W) after nLDL injection. Endothelium-dependent relaxations, the ratio of ICP to mean arterial pressure (MAP; ICP/MAP), plasma ADMA levels and eNOS mRNA and protein levels were evaluated. The ICP/MAP ratio decreased in both the 2W and 8W groups. Endothelium-dependent relaxation responses to acetylcholine in the rat thoracic aorta were damaged in the 8W group. Plasma ADMA levels increased in the 8W group. mRNA expression of eNOS decreased in a time-dependent manner, whereas the protein expression increased. These results suggest that acute nLDL injection-induced impairments in erectile functions during an 8-week period are irreversible and might be related to an increase in ADMA levels and changes in the regulation of the eNOS/NO pathway.
Similar articles
-
Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model.Andrology. 2016 Nov;4(6):1209-1216. doi: 10.1111/andr.12273. Epub 2016 Aug 27. Andrology. 2016. PMID: 27565759
-
Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil.BJU Int. 2010 Jul;106(1):78-83. doi: 10.1111/j.1464-410X.2009.09104.x. Epub 2009 Dec 11. BJU Int. 2010. PMID: 20002674
-
Testosterone Deficiency Causes Endothelial Dysfunction via Elevation of Asymmetric Dimethylarginine and Oxidative Stress in Castrated Rats.J Sex Med. 2017 Dec;14(12):1540-1548. doi: 10.1016/j.jsxm.2017.11.001. J Sex Med. 2017. PMID: 29198509
-
Endothelial nitric oxide synthase gene therapy for erectile dysfunction.Curr Pharm Des. 2005;11(31):4059-67. doi: 10.2174/138161205774913345. Curr Pharm Des. 2005. PMID: 16378511 Review.
-
Erectile dysfunction and lipid disorders.Curr Med Res Opin. 2000;16 Suppl 1:s9-12. doi: 10.1185/0300799009117033. Curr Med Res Opin. 2000. PMID: 11329828 Review.
Cited by
-
Pharmacological actions of the bioactive compounds of Epimedium on the male reproductive system: current status and future perspective.Asian J Androl. 2025 Jan 1;27(1):20-29. doi: 10.4103/aja20248. Epub 2024 Jul 9. Asian J Androl. 2025. PMID: 38978290 Free PMC article. Review.
-
Effect of Icariside II and Metformin on Penile Erectile Function, Histological Structure, Mitochondrial Autophagy, Glucose-Lipid Metabolism, Angiotensin II and Sex Hormone in Type 2 Diabetic Rats With Erectile Dysfunction.Sex Med. 2020 Jun;8(2):168-177. doi: 10.1016/j.esxm.2020.01.006. Epub 2020 Mar 5. Sex Med. 2020. PMID: 32147433 Free PMC article.
-
Prevalence and associated factors of erectile dysfunction in men with type 2 diabetes mellitus in eastern Sudan.BMC Endocr Disord. 2022 May 28;22(1):141. doi: 10.1186/s12902-022-01060-0. BMC Endocr Disord. 2022. PMID: 35643513 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical